EnzymeRx Report issue

For profit Phase 1
Founded: Paramus NJ United States (2008)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2009
NCT01021241
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

EnzymeRx, LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

pegsiticase (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperuricemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1